I DENTIFICATION of fibrinous or fibrinogenous deposits in vascular tissue suggests that the material resulted from conversion of fibrinogen to fibrin. However, fibrinogen is one of the most easily precipitable proteins of plasma, and its deposition could result from coprecipitation or formation of insoluble complexes with polyelectrolytes. Because the methods used have not differentiated between fibrinogen and fibrin in the deposits, another approach to identification of thrombin activity is needed. Measurement of the by-products and intermediates in the conversion of fibrinogen to fibrin is the subject of the present communication.
Enzymatic conversion of fibrinogen to fibrin by thrombin involves release of several peptides, designated cofibrins. 1 ' 2 Because of the stoichiometric relationship between peptide release and fibrin formation, recovery of cofibrins from plasma and urine should provide a measure of conversion. Recovery of cofibrins from urine appeared to be feasible, because Christensen, Lynch, and Powers 3 had shown that peptides from partially hydrolyzed casein were rapidly excreted in urine.
Bettelheim, 4 Blomback and Vestermark, 5 and Blomback and Laurent 6 showed that cofibrins of bovine fibrinogen are released at different rates, and that fibrin-intermediates, consisting of fibrinogen that has lost only a portion of the cofibrins, are formed during conversion to fibrin. However, the interme-From the Research Division of the Cleveland Clinic Foundation and the Frank E. Bunts Educational Institute, Cleveland, Ohio.
Supported in part by a training grant HTS-5216 from the National Heart Institute, Public Health Service, Bethesda, Md.
Presented in part at the Fourth Annual Meeting of the Biophysical Society, February, 1960, Philadelphia, Pa.
Received for publication May 5, 1960. diates were not isolated. If isolation from plasma were possible, they could be used as a measure of intravascular thrombin activity. Thomas , Smith, and Von Korff 7 described a coagulable protein that was precipitable in the cold by adding heparin to plasma from endotoxin-treated rabbits. This heparin-precipitable protein was not found in plasma from endotoxin-treated rabbits that had also received heparin. They believed it to be fibrinogen in a stage of polymerization part way in its conversion to fibrin. We attempted to obtain physical evidence for identifying it with fibrin-intermediates, but abandoned these studies because they were complicated by the presence of heparin. An abnormal, coagulable protein that we have designated as "cryoprofibrin"* was isolable without use of heparin by low temperature precipitation of a portion of freshly prepared Colin fraction I 8 from p'asma of endotoxin-treated rabbits. We describe the identification of cryoprofibrin as a mixture of fibrinogen and fibrin-intermediates, based on measurement of the cofibrins liberated after reacting fibrinogen and cryoprofibrin with thrombin.
Methods

Babbit Plasma and Urine
Citrated blood was obtained by heart puncture 1 of albino rabbits weighing 2 to 3 Kg. Plasma, kept at about 0 C, was prepared by centrifugntion at 2,500 and 4,000 r.p.in. in siliconized tubes. Rabbit-brain thromboplastin used for coagulating samples of recalcifled plasma was prepared as specified by the manufacturer, Difco Laboratories, Detroit, Mich. Urine was collected in icc-*The name cryoprofibrin is suggested for the coagulable protein contained in the precipitate to distinguish it from fibrinogen and fibrin, because it has tentatively been shown to consist largely of fibrinintermediates. The suffix "profibrin" describes it as a precursor of fibrin, and the prefix "cryo" differentiates it as a cold-precipitable fraction. cooled receptacles fitted to a metabolism cage and was clarified by centrifugation at 5,000 r.p.m. for 1 hour. Rabbits treated with 25 (xg. E. coli lipopolysaccharide (Difco Laboratories) were bled 4 hours after intravenous injection. The lipopolysnccharide was tested for potency in production of the bilateral renal necrosis described by Thomas and Good." Appropriately spaced doses of 100 /xg. and of 200 /xg. produced the necrosis in 1 of 4, and in 3 of 4 rabbits, respectively.
Isolation of Cofibrins from Tiring, Plasma, and Fibrinogen Specimens
Cofibrins were partitioned into 6 ml. of a phenolic phase from 80 ml. of rabbit's urine containing 5 per cent trichloracetic acid (TCA). An equal volume of water was added to the extract, and phenol and TCA were removed by continuous extraction. with ligroin (B.P. 30-60 C.) and with ether. The extracted solution was diluted with an equal volume of 0.05 M lithium acetate at pH 4, was percolated through 2 ml. of Dowex 50 in lithium cycle, and was reacted with HC1 to form LiCl. Contaminants were extracted into 3 volumes of benzyl alcohol containing 1 per cent formic acid. The aqueous phase was extracted with ether, and evaporated to 0.5 ml. Additional contaminants were precipitated with 3 ml. methanol and 0.5 ml. ether. Peptides were precipitated with 18 volumes of ether, and underwent eleetrophoresis on Whatman 3M paper in 0.05 M ammonium acetate at pH 4.0 for 13 hours at 9 volts/cm. One of the cofibrins, cofibrin A, was measured after elution from the appropriate region of the strip and an additional electrophoresis in 0.05 M borate at pH 8.5 for 4 hours at 15 volts/cm, on S & S 2043A gl paper. Strips were dried at 110 C. for 15 min., and were stained by a Sakaguchi reaction.
Plasma was diluted with an equal volume of saline and deproteinized with 5 per cent TCA, after which cofibrins w T ere extracted into phenol. Plasma samples from which Cohn fraction I was removed were extracted twice with 3 volumes of 3 :1 mixture of ligroin and ether to remove alcohol prior to extraction with phenol. The phenol extracts were suspended in an equal volume of water, and phenol and TCA, were removed by extraction with ligroin-ether mixture and with ether alone. The extracts were concentrated in vacuo to 0.2 ml. in conical tubes by means of a rotating evaporator, were spotted on to paper strips, and underwent electrophoresis as did extracts of urine.
In tests for cofibrin in fibrinogen specimens, fibrinogen was precipitated by adding one-third volume of saturated ammonium sulfate, and other protein by adding 5 per cent TCA. Then cofibrins were extracted into phenol, the phenol was re-moved, and the peptides were measured after electrophoresis at pH 4.
Separation of Fibrinogen and Cryoprofibrin
Fibrinogen was precipitated as Cohn fraction I from ca. 30 ml. samples of plasma. The precipitate was washed at -4 C. with 1 M glycine solution 10 and with S per cent ethanol in 0.12 M ammonium acetate, was rapidly dissolved at 37 C. in 12 ml. of 0.4 M ammonium acetate at pH 6.8, and was diluted to contain 0.15 M acetate by adding cold water. The solution was stored and gently agitated at 3 C. for 2 hours. The flocculent precipitate formed in the cold, containing cryoprofibrin, was dissolved at 37 C. in 1 ml. of 0.3 M NaBr and diluted with 7 ml. of ammonium acetate and 3 ml. of a sodium acetate-barbital buffer solution, pH 7.5, 0.15 L/2. Ten ml. portions of the cold-soluble fibrinogen solution were diluted with 5 ml. of buffer.
Analysis of Clot Liquors from Fibrinogen and Cryoprofibrin
Specimens, 15 ml. of fibrinogen and 11 ml. of cryoprofibrin, were coagulated by reaction with 10 NTH units of bovine thrombin (0.5 ing.).* The liquors were extruded from the gels. Fibrin clots were washed with water, dried, and weighed. Noncoagulable protein was precipitated from the liquors by adding 5 per cent TCA, and measured with Folin phenol reagent as used by Lowry, Rosebrough, Farr, and Randall. 11 The cofibrins were separated from the deproteinized liquors and measured as follows:
The deproteinized clot liquors were extracted with 3:1 ligroin-ether mixture to remove TCA, and were concentrated to 1.5 ml. by evaporation. The concentrated solutions were desalted by passage through a column of Sephadex G-25. The principle for use of Sephadex for desalting is described by Porath and Flodin. 12 We used 1 em. diameter columns containing 3 Gm. of Sephadex that was packed into a volume of 12.2 ml. in presence of saline, and subsequently equilibrated with 0.05 M pyridine. To circumvent possible systematic errors, newly packed columns were prepared for each desalting operation. Cofibrins were recovered in the first 8.5 ml. of effluent solution, while salt appeared in the effluent solution beyond that. The 8.5 ml. solutions were evaporated to 0.2 ml., spotted on to S&S paper strips, and subjected to electrophoresis for 12 hours at 7.8 volts/cm, in 0.05 M sodium acetate at pH 4.0. The regions containing each cofibrin were cut from the strips, the sections were suspended in 1.5 ml. of 1 per cent KOH, and the eluates were clarified by centrifugation. Cofibrins *Parke, Davis & Co., Detroit, Mich.
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were measured in the eluates by means of the Sakaguchi reaction.
Sakaguchi Reaction
Two procedures were used for measurement of cofibrins. One, used for staining the paper strips, was more useful for detecting small amounts of cofibrins and for distinguishing cofibrins from materials in nearby zones. In the other, cofibrins were eluted from the strips and the reaction conducted in the eluates; it was used for the more accurate measurements where there was no contamination of the regions surrounding cofibrins.
Cofibrins isolated from plasma and urine were measured directly on the paper strips. Strips were: (1) drawn through a solution of 0.25 ml. of 40 per cent urea, 13 1 ml. of saturated KOH, 30 ml. of 0.1 per cent 8-hydroxyquinoline in ethanol, and 70 ml. of ether; (2) dried with air;
(3) sprayed until wet with 0.5 per cent bromine in 5 per cent KOH; and (4) dried in vacuo. Color was measured by densitometry at 500 m,a with a Spinco Analytrol (Specialized Instruments Corporation, Bolmont, California). Amounts of purified eofibrins could he estimated in the range equivalent to 1.5-25 millimicromoles arginine by densitometry.
Cofibrins isolated from clot liquors of fibrinogen and eryoprofibrin were measured in the eluates from paper strips. One ml. of the eluate containing 1 per cent KOH was transferred to a 13 x 100 mm. test tube. Two-tenths ml. of 0.1 per cent 8-hydroxyquinoline was added, and the tube was chilled in an ice hath. Two-tenths ml. of 0.5 per cent N-bromosuceinimide, 14 freshly prepared, was blown rapidly into the solution by means of a Kimble No. 37051 pipette (Owens-Illinois, Toledo, Ohio), and was mixed vigorously. After 15 seconds, 0.10 ml. of 40 per cent urea was added. Within another 15 seconds the optical density was measured at 520 m^u, in 1 cm. cuvettes by means of a Beckman DU spectrophotometer. The color was stable for several minutes at 0 C. The amount of eofibrin was expressed as arginine content of the eluate. The extinction coefficient of arginine corresponded to 8.85/micromole/ml. test solution, and was independent of concentrations up to 0.1 micromole/ml. The optical densities of cofibrins were the same whether measured directly or after liberation of arginine by hydrolysis with 6 N HCl in a sealed tube at 100 C. for 16 hours.
Results
Clotting of Babbit Fibrinogen
Two different peptides, tentatively designated cofibrins A and B, are liberated presumably by action of rabbit thrombin on rabbit fibrinogen during the reaction of rabbit-
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Cofibrin A -
Origin
Figure 1
Cofibrins liberated during reaction of recalcified rabbit's plasma with rabbit brain thromboplastin. Eight milliliters of citrated plasma was reacted with 8 ml. of 0.15 M NaCl, containing 0.02' M CaCl ei mixed with 4 ml. thromboplastin extracted from 150 mg. of Difco product. Strips contain materials from a phenol extract of the reactixm mixture. Electrophoresis was at p~EL 4.0 only. The contaminating material just below the region for eofibrin A on strip A does not migrate as eofibrin A on electrophoresis at pH 8.5, and was not present in clot liquors of fibrinogen or eryoprofibrin. Clotting time was between 11 and 16 seconds. Reaction time: strip A, TCA was added immediately after thromboplastin; strip B, 8 seconds afterwards; strip C, 180 seconds afterwards.
brain thromboplastin, with recalcified rabbit plasma ( fig. 1 ). Liberation of eofibrin A occurs at a much greater initial rate than that of eofibrin B : when the reaction was stopped before completion, it was noted that about half of the eofibrin A was liberated before eofibrin B was detectable ( fig. 1 ). The liberation of eofibrin B was concurrent with visible increases in turbidity of the reaction mixture. Cofibrins A and B were liberated in the same order during the reaction of purified fibrinogen with the bovine thrombin preparation, at pH values between 6.8 and 7.6, fibrinogen concentrations near 2 mg./ml., and thrombin concentrations between 0.001 and 0.01 mg./ml. The thrombin used was sufficiently free from contaminating proteases to enable identification and measurement of products of action of thrombin, because it liberated the cofibrins of bovine fibrinogen in the general manner described by others 4 studied the reaction with more highly purified thrombin and who demonstrated more rigorously the significance of release of cofibrins by thrombin. It was concluded that bovine and rabbit thrombin have the same action on rabbit fibrinogen. Because cofibrin A was the only peptide recovered during the initial portion of the reaction with thromboplastin, it is possible that intermediates of fibrin which have lost only cofibrin A are produced during physiologic conversion of fibrinogen to fibrin.
Nonexcretion of Cofibrin
Results of analyses of 80 ml. specimens of rabbit's urine containing added cofibrin A in amounts up to equivalents of 30 millimicromoles of arginine are reproduced in figure 2. Recoveries of cofibrin A ranged from 30 to 50 per cent in these and in 7 other analyses. Recoveries of eofibrin B were of the order of 10 per cent. Incubation of urine for 3 hours at 37 C. destroyed what appeared to be less than 50 per cent of added cofibrin A. The amounts of cofibrin added to the urine were less than one-half that calculated to occur if clotting is involved in physiologic turnover of fibrinogen and if cofibrins are excreted without degradation. Cofibrins were detectable only when added to urine.
Cofibrin A could not be detected in urine specimens collected during a 3-and a 12-hour period after intravenous injection into a rabbit of cofibrin A equivalent to 3 micromoles of arginine. Accordingly, less than 1 per cent of cofibrin A was excreted. Recovery of cofibrin A from urine would not provide a practical approach to study of clotting in vivo.
Composition of Cryoprofibrin and Fibrinogen Preparations
The amounts of cryoprofibrin obtained from 11 endotoxin-treated and from 5 untreated rabbits corresponded respectively to 0.264 ± 0.038 (S.B.M.) and to 0.044 ± 0.016 mg./ml. of plasma. The rise in cryoprofibrin after endotoxin-treatment suggests that it is the same as the heparin-precipitable fibrinogen. The amounts of cryoprofibrin isolated from treated rabbits were about the same as those reported for heparin-precipitable fibrinogen (0.4 to 0.6 mg./ml. without correction for noncoagulable protein). 7 The amounts of cryoprofibrin derived from endotoxin-treated rabbits are nearly quantitative measures of coagulable protein with abnormal solubility iu the cold. Approximately 70 per cent of the total coagu'.able protein of plasma was recovered iu the washed specimens of Colin fraction I, and recovery of cryoprofibrin from the washed Colin fraction I was nearly complete because storage of solutions at a lower temperature of 0 C, or for 6 times as long, did not result in additional precipitation of protein.
Noncoagulable protein in cryoprofibrin and fibrinogen preparations was estimated by measuring protein precipitated from clot liquors with TCA. The amount found was about the same as that of thrombin added. It was not possible to correct for the contribution of thrombin to the measurement, because precipitation of thrombin was dependent of presence of other protein. At least 80 to 90 per cent of the total protein in 6 cryoprofibrin and 93 per cent in 4 fibrinogen specimens derived from endotoxin-treated rabbits was coagulable.
Pibrinogen isolated from 1 normal and 2
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Cofibrins of Rabbit Fibrinogen and Cryoprofibrin
The cofibrins liberated from fibriuogen and cryoprofibrin by coagulating specimens with thrombin were isolated and measured as already described. The results are summarized in table 1. The amounts of cofibrin B obtained from fibrinogen and crj'oprofibrin were the same, 4.05 ± 0.22 (S.E.M.) millimicromoles arginine per mg. fibrin clot, within experimental error. The amount of cofibrin A obtained from cryoprofibrin was 30 ± 3 (S.E.M.) per cent less than from fibrinogen, as indicated by the smaller ratio of cofibrins (A/B) obtained from cryoprofibrin.
The ratio of cofibrins (A/B) was equal to 1.1 ± 0.02 (S.E.M.) for fibrinogen. The statistically significant 10 per cent deviation of the ratio from unity indicates there was a small systematical error in the analyses of cofibrins. As discussed later, the larger amount of cofibrin A relative to B did not result from liberation of cofibrin A during separation of fibrinogen and cryoprofibrin. The error probably resulted from a slight preferential loss of cofibrin B when the samples were coagulated with thrombin. Because the treatment of clot liquors from cryoprofibrin and fibrinogen was the same, it can be assumed Circulation Research, Volume VIII, September I960 that the systematic error was the same for both materials. The amounts of cofibrins recovered from clot liquors provide reasonably accurate measures, after correction for the error in B, of the amounts liberated for the following reasons: 1. When known amounts of cofibrins, or mixtures of cofibrins and thrombin, were analyzed the cofibrins were quantitatively recovered within the 1.2 millimicromole accuracy of the Sakaguchi reaction. 2. Adsorption of cofibrins by fibrin clots was small because cofibrins were not found in an extract obtained by dissolving an 18 mg. clot (previously rinsed with 1 ml. of 0.15 M ammonium acetate) in 2 per cent acetic acid and subsequently precipitating fibrin with TCA.
The amount of cofibrin A and B liberated from fibrinogen was equivalent to 1.0 and 0.9 moles of arginine, respectively, in formation of 220,000 Gm. of fibrin. Assuming that the configuration of rabbit fibrinogen is similar to that of other species, and that thrombin liberates 2 molecules of each cofibriu as is true for other fibrinogens studied by Blomback and Laurent, 0 then the cofibrins of rabbit fibrinogen contain one residue of arginine per peptide molecule. This arginine content is consistent with results of determination of amino acid compositions of the rabbit cofibrins as told us by others.*
The 30 per cent smaller yield of cofibrin A from cryoprofibrin as compared with fibrinogen supports the hypothesis that cryoprofibrin consists in part of fibrin-intermediates that have lost cofibrin A by action of thrombin prior to separation of fibrinogen and cryoprofibrin. The yield of cofibrin A from cryoprofibrin corresponds approximately to *Drs. E. C. Wolff, J. E. Folk, and J. A. Gladner, National Institutes of Health, Bethesda, M<J, SHAINOPF, PAGE a deficit of 2 molecules of cofibrin A in the formation of 3 molecules of fibrin. Because intermediates of fibrin may possess either 1 or no molecules of cofibrin A, the intermediates constitute between one-third and twothirds of the cryoprofibrin.
Intravascular Origin of Cryoprofibrin
The preceding analyses indicated that cryoprofibrin contains an average of 30 per cent less eofibrin A that can be liberated by thrombin than does fibrinogen. To determine whether the deficient cofibrin could have been liberated in the period subsequent to exsanguination and prior to separation of cryoprofibrin and fibrinogen, plasma and fibrinogen were analyzed for presence of free cofibrin.
Free cofibrin A could not be detected in 6 specimens of fibrinogen derived from endotoxin-treated rabbits. One had yielded 18 mg. of cryoprofibrin, and each of the others yielded approximately 10 mg. cryoprofibrin. If the cryoprofibrin had been produced by action of thrombin during storage, cofibrin A equivalent to 15-25 millimicromoles of arginine should have been found.* Control studies on recovery of added cofibrins indicated the tests were sensitive to 4 millimicromoles. Accordingly, less than one-sixth of the cryoprofibrin was produced while cryoprofibrin was being separated from fibrinogen. A more sensitive criterion for absence of thrombin activity in fibrinogen specimens was provided in the observation that additional precipitation, hence formation, of cryoprofibrin did not occur on prolonged storage (12 hours) at 3 C. or after several fibrogen specimens were incubated for 5 minutes at 37 C.
Estimations of cofibrin A in plasma were based on comparison of the amounts isolated with those recovered from samples to. which cofibrin was added. The supernatant-plasma that remained after precipitation of Cohn fraction I from one 120 ml. and two 60 ml. samples of plasma from 8 endotoxin-treated rabbits was analyzed for cofibrin in this man-*(Average cofibrin liberatod/mg. fibrinogen-averago cofibrin liberated/mg. cryoprofibrin) x m gcryoprofibrin found in sample, ner. The samples had yielded 32, 16, and 10 mg. of cryoprofibrin. Cofibrin A could not be detected in the two smaller samples, whereas it was easily detected when 13 millimicromoles were added to normal blood ( fig.  3, strips A and C) . Accordingly, the samples contained an amount much less than 13 millimicromoles. The amount of cofibrin found in the largest sample corresponded to about 13 millimicromoles ( fig. 3, strip D) . If the cryoprofibrin derived from these samples had been produced by action of thrombin during exsanguination and isolation of Cohn fraction I, 14 to 44 millimicromoles should have been found.* Accordingly, about one-third of the fibrin-intermediates in cryoprofibrin could have been produced during manipulation of citrated blood and plasma, and it is probable that at least two-thirds of the fibrin-intermediates could have been produced by action of thrombin in vivo.
The reason for the presence of any cofibrin at all is of interest. Fifty ml. samples of blood were drawn into citrate and chilled within 1 minute. It is possible that the cofibrin was liberated during this period because a much larger amount of cofibrin A, equivalent to 20-30 millimicromo'.es arginine, was found in a sample of citrated normal blood that stood at room temperature for 15 minutes before being chilled in an ice bath and centrifuged ( fig. 3, strip B) . The larger amount of cofibrin found in this sample could have resulted from action of pre-existing thrombin, as well as thrombin activated during exsanguination. This experiment demonstrates the importance of rapidly chilling the blood after it is drawn.
Discussion Measurement of the cofibrins liberated on reaction of cryoprofibrin with thrombin provided evidence that eryoprofibrin consists in part of intermediates in the conversion by thrombin of fibrinogen to fibrin. Because the average yield of cofibrin A (equivalent to 0.7 moles of arginiue per 220,000 Gin. fibrin clot) from cryoprofibrin was 30 per cent smaller *cf. formula in previous footnote. (13 units) to 50 ml. of citrated normal blood. The cofibrin was contained in the citrate used as anticoagulant. B. Detection of cofibrin A in extract derived from 100 ml. of citrated normal blood that had stood at room temperature for 15 minutes. C. Absence of cofibrin in extract from 60 ml. of plasma that had yielded 16 mg. of cryoprofibrin. This strip differs from the others in its general appearance because a larger area ivas eluted from the strip on which electrophoresis at pH 4.0 was conducted. ~D. Detection of cofibrin in extract from 120 ml. of plasma that had yielded 32 mg. of cryoprofibrin. The amount detected, as initially observed, was about the same as that recovered in strip A. E. Cofibrin recovered after addition of 26 units to 50 ml. of citrated normal blood. F. Absence of cofibrin in extract from 50 ml. of citrated normal blood with no cofibrin added. than from fibrinogen, cryoprofibrin probably consists of fibrinogen which had lost cofibrin A. The yield of cofibrin B was the same for cryoprofibrin as for fibrinogen (0.9 moles per 220,000 Gm. fibrin). The preferential deficit of cofibrin A rather than cofibrin B provides evidence the cofibrin was lost by limited action of thrombin on fibrinogen because cofibrin A is liberated from fibrinogen by thrombin more rapidly than is cofibrin B.
Cryoprofibrin does not consist of a mixture of fibrinogen and fibrin because fibrin is virtually insoluble under conditions used for solubilization of cryoprofibrin, and because the ratio of cofibrins (A/B) liberated by action of thrombin on cryoprofibrin is inconsistent Avith this hypothesis.
Although an unidentified protease may have been responsible for production of cryoprofibrin, the protease had specificity similar to thrombin. Thrombin is the only known Circulation Research, Volume VIII, September 1960 plasma protease that releases cofibrins in a manner consistent with that responsible for the cofibrin content of cryoprofibrin. Plasmin is excluded because the products of degradation of fibrinogen by plasmin described by Sherry and Alkjaersig 16 and Shulman 17 are not clottable, and cryoprofibrin is clottable. The studies by Wal'.en and Bergstrom 18 demonstrated that limited action of plasmin does not release or digest cofibrins of bovine fibrinogen, and it is likely that plasmin would not act differently on. rabbit fibrinogen. Furthermore, Thomas, Smith, and Von Korff 7 found in endotoxin-treated rabbits that the appearance of a protein similar to cryoprofibrin, "heparin-preeipitable fibrogen," is prevented by heparin. The tentative identification of fibrin-intermediates in cryoprofibrin indicates that the prevention resulted from the antithrombin activity of heparin.
It is important to distinguish between throm-
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bin activity in vivo and that observed after blood or vascular tissue is sampled, because blood retains its fluidity in vivo but coagulates on contact with wettable surfaces and in isolated segments of vein. 1 "' -° Measurement of cofibrin A in b'.ood provided an estimate of the amount that could have been liberated after exsanguination, because that liberated in vivo and absorbed by tissue was not recoverable. The amount of cofibrin found was less than one-third that lost in the formation of the fibrin-intermediates contained in cryoprofibrin. Accordingly, two-thirds or more of the fibrin-intermediates derived from the endotoxin-treated rabbits could have been produced by action of thrombin in vivo.
Our results indicate that measurement of fibrin-intermediates may be used to determine thrombin activity in vivo. Quantitative application would require knowledge of kinetics of production and of intravascular half-life of the intermediates. Because the intermediates of fibrin have different compositions, depending on the number and nature of cofibrins that had been liberated from fibrinogen, it may be possible to distinguish them by clectrophoresis to provide additional parameters for measurement of thrombin activity.
Although intravascular deposition of malerial derived from fibrinogen, such as fibrinoid of the generalized Shwartzman reaction, can be demonstrated by iminunohistological methods, 21 knowledge of thrombin activity during deposition could give a clue as to the nature of the deposit. Immunohistological methods do not differentiate between fibrin, fibrin-intermediates, and fibrinogen. Our studies provide strong evidence for implicating thrombin in the mechanism of fibrinoid deposition. "We have shown that increase in thrombin activity, as indicated by a six-fold increase in cryoprofibrin, occurs after endotoxin-treatment. Although we made no morphologic studies, the increase in thrombin activity was probably concomitant with fibrinoid deposition, because Branson, Gamble, and Thomas 1 '-showed that fibriuoid can be found after a single treatment of rabbits with endotoxin. It has been suggested by Thomas et al."'-:< that fibrinoid is derived from fibrinogen in a stage of polymerization part way in its conversion to fibrin. This possibility is supported by the present identification of fibrin-intermediates in plasma of endotoxin-treated rabbits. However, it is likely that fibrinoid may contain intermediates lacking a greater portion of cofibrins than observed in cryoprofibrin.
Study of fibrin-intermediates is useful for discriminating between a generalized or localized origin of fibrin deposited in lesions. Eecovery of fibrin-intermediates from plasma provides circumstantial evidence for a generalized origin. Study of the conversion of fibrinogen to fibriu in A' ivo may give a clue as to the validity of Duguid's 24 hypothesis that atherosclerosis has its origin in the deposition of fibrin on the endothelium of blood vessels and Astrup's 2 "' concept that fibrin is continuously being deposited and redissolved. The intermediates of human fibrin are now under study. Summary A cold-preeipitable, thrombin-eoagulable protein, tentatively designated "eryoprofibrin," Avas separated from plasma of rabbits treated with E. coli endotoxin. It was shown to contain fibrin-intermediates, consisting of fibrinogen that has lost only a portion of the peptides liberated during the conversion of rabbit fibrinogen to fibrin. These peptides have been called cofibrins. On reaction with thrombin, fibrinogen and cryoprofibrin yielded the same amount of cofibrin B (0.9 moles per 220,000 6m. of fibrin clot) ; however, cryoprofibrin yielded 30 per cent less cofibrin A than did fibrinogen. Cryoprofibrin and fibrinogen yielded 0.7 and 1.0 moles of cofibrin A per 220,000 Gm. of fibrin, respectively. The deficit of cofibrin A in preference to cofibrin B provides evidence that, cryoprofibrin consists of fibrinogen that had lost cofibrin A by limited action of thrombin, because cofibrin A is liberated from fibrinogen by thrombin more rapidly than is cofibrin B.
Only a small portion of the cryoprofibrin could have been produced by action of throm-Circulation Research. Volume Vlll. September 1000 bin subsequent to exsanguination, because the plasma contained only about one-third of the cofibrin A that had been liberated from fibrinogen during its conversion to cryoprofibrin. Accordingly, cryoprofibrin provides a valid measure of thrombin activity in vivo, at least in the endotoxin-treated rabbits.
An alternative approach to measurement of thrombin activity involving recovery of cofibrin A from urine proved inapplicable, because no confibrin A was found to be excreted in urine.
An average of 0.264 ± 0.038 mg. cryoprofibrin per ml. was obtained from plasma of treated rabbits, as compared with 0.044 ± 0.016 mg. of cold-precipitable fibrinogen per ml. of normal plasma. The demonstration of increased thrombin activity after endotoxin treatment, as evidenced by the cryoprofibrin, implicates thrombin in the mechanism of fibrinoid deposition. The demonstration that cryoprofibrin consists of fibrin-intermediates supports Thomas' hypothesis that fibrinoid consists of fibrin-intermediates.
Summario in Interlingua
Un cryoprecipitabile e thrombino-congulabile proteina.-tentntivemente designate como "cryoprofibriiiii"-esseva separate ab le plasma de conilios tractate eon endotoxina. de Escherichia coli. Esseva demonstrate que illo contincva intermediaries fibrinogeno-fibrinic que consistova. de fibrinogeno que liabeva perdite solmente un portion del peptidos que es liberate in le curso del conversion de flbrinogeno de conilio in fibrina. Iste peptidos lia essite designate como cofibrinas. In le reliction con thrombina, fibrinogeno e eryoprofibrina rendeva le nicsnic qimntitate de cofibrina B, i.e. 0,9 mol per 220.000 g de coagulo de fibrina. Tameii, eryoprofibrina-in coinparation con flbrinogeno-rendeva 30 pro cento minus cofibrina A. Cryoprofibrina. e fibrinogeuo rendeva 0,7 et 1,0 mol de cofibrina A per 220.000 g de fibrina, respectivemente. Le deficit de cofibrina A in preferentia a cofibrina. B provide un indicio que cryoprofibrina consisto de fibrinogeuo que lia i)erdite cofibrina A per un action limitate de tlirombina, proque cofibrina A on liher:i.tu ab fibrinogeno per tlirombina plus rapideniciite quo cofibrina B.
II pare clar que solmente un niicre portion del eryoprofibrina, pote liaber essite producitc per le action de tlirombina post le exsanguination, proque !e plasma eontineva, solmente circa un tertio del eofibrina. A que liabeva essite liberate ab fibrinogeno (lui'iiiito su conversion in cryoprofibrina. Per conse-quente, cryoprofibrina provide un valido niesura del r.ctivitate de thrombina in vivo, al minus in conilios tractate con endotoxina.
Un socunde tlieoria methodologic pro le mesuratioii del activitate de tlirombina, basate super le recuperation de cofibrina A ab le urina, non esseva applicabile al practiea, proque il esseva trovate que nullc cofibrina A esseva excernite in le urina.
Esseva obtenite al media 0,264±0,038 nig de cryoprofibrina per ml de plasmn. del tractate conilios, in eomparation con 0,044±0,016 mg de cryoprecipitabilu fibrinogeno per ml de plasma normal. Le demonstration de un augmentate activitate de tlirombina post le tractaniento con endotoxina-nianifeste in le cryoprofibrina-iinplica tlirombina in le nieclianismo del deposition de fibrinoide. Le demonstration que cryoprofibrina consiste (le intermediarios fibrinogeno-fibrinic supporta le hypotliese de Thomas que fibrinoide eonsisle de intermediarios fibrinogeno-fibrinic.
